The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 259 | 296 | 235 | 236 |
| Depreciation and amortization | 142 | 143 | 140 | 135 |
| Provision for credit losses | 0 | 1 | -3 | 5 |
| Deferred income tax expense (benefit) | 110 | 1 | 7 | 34 |
| Stock-based compensation expense | 20 | 21 | 22 | 27 |
| Other, net | -11 | -27 | 1 | 2 |
| Accounts receivable | 38 | 14 | 101 | -69 |
| Accounts payable and accrued expenses | 124 | 42 | -53 | 35 |
| Income taxes payable | -10 | -6 | 15 | -15 |
| Other assets and liabilities, net | 55 | -33 | -49 | 56 |
| Net cash provided by operating activities | 563 | 544 | 314 | 464 |
| Business acquisitions, net of cash acquired | 34 | 17 | 0 | 383 |
| Capital expenditures | 144 | 108 | 117 | 123 |
| Other investing activities, net | 23 | -1 | -2 | -4 |
| Net cash used in investing activities | -201 | -124 | -115 | -502 |
| Proceeds from borrowings | 10 | 185 | 215 | 0 |
| Repayments of debt | 10 | 401 | 600 | 1 |
| Purchases of treasury stock | 150 | - | - | 151 |
| Exercise of stock options | 19 | 13 | 29 | 21 |
| Employee payroll tax withholdings on stock issued under stock-based compensation plans | 2 | 0 | 42 | 0 |
| Dividends paid | 89 | 90 | 84 | 84 |
| Distributions to noncontrolling interest partners | 14 | 11 | 18 | 12 |
| Other financing activities, net | -11 | 11 | -61 | 57 |
| Net cash (used in) provided by financing activities | -247 | -293 | -561 | -170 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -2 | 4 | 1 | -7 |
| Net change in cash and cash equivalents and restricted cash | 113 | 131 | -361 | -215 |
| Cash and cash equivalents at beginning of period | 319 | 188 | 549 | 764 |
| Cash and cash equivalents at end of period | 432 | 319 | 188 | 549 |
QUEST DIAGNOSTICS INC (DGX)
QUEST DIAGNOSTICS INC (DGX)